Avantium Launches €55 Million Raise After Plant-Based Plastics Delays
Avantium launched a €55.45 million rights offering on 27 October 2026 after delays at its first commercial plant-based plastics facility created a projected €33 million working-capital shortfall. The financing is fully covered by shareholder commitments, cornerstone investors and underwriters, but the filing makes clear that industrial proof and financial survival are now tightly linked.
The Amsterdam-listed company is offering 33,608,956 new shares at €1.65 each, with four new shares available for every three rights held. The issue price is 42.7% below the theoretical ex-rights price and 63.5% below Avantium's 26 October closing share price. The company expects about €50.5 million of net proceeds after approximately €5 million of transaction costs, according to its 27 October financing announcement.
Why this is more than a routine share sale
Avantium is trying to move from technology development into repeatable industrial production. Its Delfzijl plant converts plant-derived sugars into furandicarboxylic acid, or FDCA, which is then used to make polyethylene furanoate, known as PEF. The company presents PEF as a renewable and recyclable polyester for bottles, films, food packaging, textiles and other applications.
The facility has nominal capacity of 5,000 tonnes of FDCA a year. It produced its first batch at commercial scale on 28 September, but a first batch is not the same as stable continuous output, customer qualification or commercial deliveries. Avantium says it is producing additional material and expects its first deliveries under existing offtake agreements toward the end of 2026.
That distinction matters because the rights offering is funding the gap between technical start-up and cash-generating operations. The company says the proceeds will cover the plant ramp-up, commercialization, licensing work, general corporate expenses and financing costs. The capital raise therefore buys time for execution; it does not by itself prove that the plant can reach planned output, quality or economics.
The cash position in numbers
Measure | Company disclosure or calculation |
Projected cash at end-October 2026 | Approximately €9 million |
Restricted cash buffer | Approximately €5 million |
Implied unrestricted cash | Approximately €4 million |
12-month working-capital shortfall | Approximately €33 million |
Gross rights-offering proceeds | Approximately €55.45 million |
Expected net proceeds | Approximately €50.5 million |
Net proceeds above stated shortfall | Approximately €17.5 million |
Existing FDCA-plant debt facilities | €111 million |
Proposed conditional NOM loan | €20 million |
Agrilinkage's calculation of approximately €4 million in unrestricted cash subtracts the €5 million restricted buffer from the projected €9 million balance. The roughly €17.5 million difference between expected net proceeds and the stated €33 million shortfall is intended to provide a cushion if sales or licence income arrive late or below plan. Transaction costs consume about 9% of the gross raise.
The liquidity forecast depends on €14 million of revenue from Avantium's research and development services, €9 million of product sales from the FDCA plant and €17 million of licence and pre-licence income from five parties during the relevant 12-month period. Together, product and licence assumptions account for €26 million of projected inflows. Those are not yet cash in the bank.
The prospectus summary says the group expects €71 million of working-capital outflows, mainly operating costs including plant ramp-up, plus €6 million of interest. It also says the company aims for monthly group revenue of about €7.5 million and cumulative group-level EBITDA break-even on a monthly basis from December 2027. Both targets remain conditional on commercial progress and the assumptions in the prospectus.
The offering radically expands the share count
A four-for-three issue means the 33.61 million new shares equal roughly 133% of the pre-offer share count. That implies about 25.21 million shares before the transaction and approximately 58.82 million after the base offering, before any additional placement or upsize shares. Avantium states that shareholders who do not exercise or transfer their rights would see their proportional ownership and voting rights diluted by about 57.1%.
Long-term shareholders and cornerstone investors have committed €13.41 million, equal to about 24.2% of the offering. This includes €6.06 million committed by a vehicle acting for the Dutch state, €5 million from Pieter Kooi Holding, and smaller commitments from other investors. The remaining approximately €42.04 million is underwritten, subject to customary conditions, by Invest-NL, ABN AMRO, BNP Paribas and Stifel.
Full underwriting materially lowers placement risk, but it is not the same as completed settlement. Rights trading is scheduled from 28 October to 6 November, exercise closes on 10 November and settlement is expected on 13 November. Until then, investors should distinguish a secured transaction structure from cash already received.
Plant delays explain the financing pressure
The Delfzijl plant was officially opened in October 2024, yet commissioning took far longer than originally expected. Construction-related defects in titanium welds created safety concerns, delayed oxidation and purification systems, and added approximately €7 million of capital expenditure. Avantium said the weld-repair programme was completed in April 2026.
That €7 million remediation cost alone is equivalent to almost 14% of the expected net proceeds from the new offering. More importantly, the delay deferred product sales and licence income while operating and interest expenses continued. The company and engineering contractor Worley completed a contractual close-out in September covering outstanding invoices, claims and remediation responsibilities, according to Avantium's half-year financial update.
The technical milestone achieved in September reduces one category of risk, because all major process units have been commissioned and actual FDCA has been produced. It does not eliminate ramp-up risk. The next proof points are continuous operation, repeatable product specification, customer acceptance and shipments against contracts.
Offtake is broad, but disclosed volume is limited
Avantium says it has 23 offtake agreements for material from the 5,000-tonne flagship plant. It has not disclosed the combined contracted volume, price realization or shipment schedule in the new announcement. Without those figures, the number of agreements shows commercial breadth but cannot establish plant utilization or margin.
The company also reports 17 capacity-reservation agreements representing more than 150,000 tonnes of potential annual output from future licensed facilities. That potential capacity is at least 30 times the flagship plant's nameplate output. The comparison shows that Avantium's long-term economic thesis depends heavily on licensing larger third-party plants, not only on selling material from Delfzijl.
Capacity reservations should not be read as operating plants or firm construction orders. Future projects still require investors, engineering, permits, feedstock, customers and final investment decisions. The first factory's reliability and economics will influence whether prospective licensees convert reservations into funded capacity.
The proposed €20 million loan is not an immediate cash solution
Avantium signed a term sheet on 23 October for a proposed €20 million subordinated loan from the Investment and Development Agency for the Northern Netherlands, known as NOM. The facility would be divided into four €5 million tranches linked to regional-transition milestones.
The first tranche cannot be drawn before 1 March 2027. Each draw also depends on liquidity conditions, approvals, definitive documentation, successful completion of the rights offering and the absence of a material adverse change. The loan could add headroom next year, but the rights offering remains the immediate answer to the current shortfall.
What food and packaging companies should watch
For packaging users, the decisive question is not whether PEF can be made once, but whether commercial quantities can be supplied consistently, qualified for intended applications and priced against established materials. European packaging rules are increasing pressure to reduce waste and improve recyclability, as Agrilinkage has explained in its overview of EU food-packaging requirements through 2030.
The market need is substantial: the European Union generated 35.9 kilograms of plastic-packaging waste per person in 2023, while recycling reached 42.4%, according to Eurostat data examined by Agrilinkage. New polymers still have to fit real collection, sorting and recycling systems rather than relying only on laboratory recyclability.
Avantium's financing timetable, the first qualified commercial deliveries, disclosed plant utilization, operating cash burn and progress on licence payments will provide the clearest evidence over the next several quarters. The launch of the offering is important because it exposes the cost of bridging a first-of-a-kind plant from construction into commercial operation. The technology story is now inseparable from cash discipline.
Methodology and disclosure
This article is based on Avantium's 27 October 2026 offering announcement and prospectus summary, its 2026 plant and financial updates, and Agrilinkage calculations from disclosed figures. Calculations are rounded and are not investment advice. Company forecasts, offtake claims, capacity reservations and break-even targets are identified as company statements rather than independently verified outcomes.
Related reading: CuBE's reusable food-packaging expansion offers a different route to reducing packaging waste, using durable containers rather than a new polymer.
Comments